Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
The Cleveland Clinic
This study is a prospective randomized control trial. Patients undergoing pelvic surgery will randomized into two groups. The study group will receive one oral dose of .4mg of Tamsulosin preoperatively.The control group will receive one placebo pill preoperatively. Success or failure of initial voiding trial in postoperative period will be measured. Patients who fail the voiding trial will be discharged home with Foley catheter as is standard protocol at our institution.
Age
Any age
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
i. Patient undergoing surgery for prolapse with or without mid-urethral sling procedure.
ii. Specific surgical procedures include all vaginal, laparoscopic and robotic reconstructive or obliterative surgeries including the use of mid-urethral slings
You may not be if
i. Diagnosis of urinary retention preoperatively (post void residual \>150ml)
ii. Malignancy
iii. History of neurological disease
iv. History of spinal cord injuries
v. Allergy to Tamsulosin
vi. Perioperative complications requiring prolonged postoperative bladder drainage
vii. Incontinence procedures other than mid-urethral slings
